Analysis of the inter- and intravillous placental blood circulation in high-risk pregnancies before and after the hemodilution therapy using the colour-angio-mode
H. Joern et al., Analysis of the inter- and intravillous placental blood circulation in high-risk pregnancies before and after the hemodilution therapy using the colour-angio-mode, CL HEMORH M, 22(3), 2000, pp. 205-213
Objective: The aim of the study was to examine the efficiency of a hemodilu
tion (HD) therapy on the inter- and intravillous placental blood circulatio
n in high-risk pregnancies by applying the colour-angio-mode (CAM).
Patients and methods: 24 patients were examined who had fetal growth retard
ation and/or pathological Doppler results. In all cases the hematocrit was
> 36%. The patients were given 500 ml Ringer solution and 500 ml HAES 10% i
ntravenously per day; maternal heart rate and blood pressure were measured
continuously. Prior to and after the therapy the same area of the placenta
was examined using CAM; histograms demonstrating the distribution of the in
tensity values and summation values of the color pixels were calculated.
Results: In 14 patients the fetal outcome was good. The histograms showed i
n 11/14 cases an increase of low intensity values indicating an improvement
of the placental circulation. The summation value of the color pixels as m
easured by CAM was significantly increased after the therapy in these cases
(p = 0.022). In 10 patients the fetal outcome was unfavorable. The histogr
ams showed a decrease of the intensity values in 6/10 cases. There was no s
ignificant change in the summation values of the color pixels after the the
rapy (p = 0.139).
Conclusions: CAM sonography demonstrated for the first time a local effect
of the HD therapy within the placenta. In the positive case the placental b
lood circulation will improve and the pregnancy develops favourably (respon
der). In the negative case there is no change of the placental blood circul
ation and pregnancy must be terminated due to a pathological fetal heart ra
te tracing, fetal growth failure or hypertensive disorders (nonresponder).